Tuesday, 23 July 2019

Biogen profit rises 72%

Biogen reported a 72.4% rise in second-quarter profit, boosted by higher sales of its multiple sclerosis treatment Tecfidera and lower research and development costs.

from Earnings https://ift.tt/2Z8pb6T
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)